InterVenn Biosciences

InterVenn Biosciences is a life sciences company focused on advancing personalized medicine by decoding the human glycoproteome, the collection of glycosylated proteins that play critical roles in biological processes. Their proprietary platform, GlycoVision™, utilizes artificial intelligence and machine learning to analyze the complex structures and functions of glycoproteins, enabling the discovery and validation of novel biomarkers for early disease detection, response prediction, and therapeutic monitoring.

InterVenn is committed to revolutionizing healthcare through their innovative approach to glycoproteomics. They are developing a suite of clinical laboratory-developed tests (LDTs) for various diseases, including colorectal cancer, melanoma, and ovarian cancer. They also offer their GlycoVision platform for research purposes, allowing partners to leverage the power of glycoproteomics to gain deeper insights into disease mechanisms and develop new therapeutic targets.

InterVenn Biosciences offers remote work opportunities, flexible work hours, and a work-from-home stipend, demonstrating a commitment to employee flexibility.

InterVenn Biosciences offers a comprehensive package of employee benefits designed to promote health, well-being, and financial security. These benefits include health, dental, and vision insurance, life and disability insurance, an employee assistance program, an on-site gym and fitness classes, company equity, performance bonuses, a 401(k) retirement plan, a stock purchase program, flexible work hours, remote work opportunities, commuter benefits, catered meals, and unlimited paid time off, including the last week of December off. Additionally, they offer a work-from-home stipend and a variety of holiday events to foster a positive work environment.

InterVenn Biosciences is a life sciences company committed to advancing personalized medicine by decoding the human glycoproteome – the study of glycosylated proteins, which are responsible for driving protein function. Their mission is to unlock a rich source of biological insights that can significantly improve drug development and patient outcomes by leveraging their proprietary AI-driven GlycoVision™ platform. Through this, they aim to usher in a new era of personalized, predictive, and preventive care, ultimately ensuring that no one is ever blindsided by disease.

InterVenn Biosciences fosters a culture that prioritizes scientific and data integrity, transparency, and clear communication. They encourage innovative curiosity and a strong sense of mission within a patient-driven environment where employees are valued.

InterVenn Biosciences is committed to fostering a diverse, equitable, and inclusive workplace. Their website highlights their core values of scientific and data integrity, transparency and responsibility, clear communication and mission, and innovative curiosity, all of which support a culture of respect and inclusivity. While specific details about their DEI initiatives aren't explicitly stated, the emphasis on creating an employee-first organization suggests a commitment to fair treatment and opportunities for all.